ANAPHYLAXIS - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

ANAPHYLAXIS

Description:

Causes of anaphylaxis Immunologic mechanisms IgE-mediated ... 21/100,000 patient-years food allergy 36 ... Venom immunotherapy is highly effective in ... – PowerPoint PPT presentation

Number of Views:279
Avg rating:3.0/5.0
Slides: 37
Provided by: Charle591
Category:

less

Transcript and Presenter's Notes

Title: ANAPHYLAXIS


1
ANAPHYLAXIS
2
Causes of anaphylaxis
  • Immunologic mechanisms IgE-mediated -
    drugs - foods - hymenoptera
    (stinging insects) - latex Non-IgE
    mediated - anaphylotoxins-mediated e.g.
    mismatched blood

3
Causes of anaphylaxis
  • Direct activation of mast cells - opiates,
    tubocurare, dextran, radiocontrast dyes
  • Mediators of arachidonic acid metabolism -
    Aspirin (ASA) - Nonsteroidal
    anti-inflammatory drugs (NSAIDs)
  • Mechanism unknown - Sulphites

4
Causes of anaphylaxis
  • Exercise-induced
  • food-dependent, exercise-induced
  • cold-induced
  • idiopathic

5
Risk of anaphylaxis
  • Yocum etal. (Rochester Epidemiology Project)
    1983-1987 incidence 21/100,000
    patient-years
  • food allergy 36, medications 17, insect sting
    15

6
Frequency of symptoms inAnaphylaxis
7
Anaphylaxis
  • Onset of symptoms of anaphylaxis usually in 5
    to 30 minutes can be hours later
  • A more prolonged latent period has been thought
    to be associated with a more benign course.
  • Mortality due to respiratory events (70),
    cardiovascular events (24)

8
Prevention of anaphylaxis
  • Avoid the responsible allergen (e.g. food, drug,
    latex, etc.).
  • Keep an adrenaline kit (e.g. Epipen) and Benadryl
    on hand at all times.
  • Medic Alert bracelets should be worn.
  • Venom immunotherapy is highly effective in
    protecting insect-allergic individuals.

9
Treatment of anaphylaxis
  • EPINEPHRINE (11000) SC or IM - 0.01 mg/kg
    (maximal dose 0.3-0.5 ml) - administer in a
    proximal extremity - may repeat every 10-15
    min, p.r.n.
  • EPINEPHRINE intravenously (IV) - used for
    anaphylactic shock not responding to
    therapy - monitor for cardiac arrhythmias
  • EPINEPHRINE via endotracheal tube

10
Treatment of anaphylaxis
  • Place patient in Trendelenburg position.
  • Establish and maintain airway.
  • Give oxygen via nasal cannula as needed.
  • Place a tourniquet above the reaction site
    (insect sting or injection site).
  • Epinephrine (11000) 0.1-0.3 ml at the site of
    antigen injection
  • Start IV with normal saline.

11
Treatment of anaphylaxis
  • Benadryl (diphenhydramine) - H1 antagonist
  • Tagamet (cimetidine) - H2 antagonist
  • Corticosteroid therapy hydrocortisone IV or
    prednisone po

12
Treatment of anaphylaxis
  • Biphasic courses in some cases of
    anaphylaxis - Recurrence of symptoms 1-8
    hrs later - In those with severe anaphylaxis,
    observe for 6 hours or longer. - In milder
    cases, treat with prednisone Benadryl every 4
    to 6 hours advise to return immediately for
    recurrent symptoms

13
Treatment of Anaphylaxis in Beta Blocked Patients
  • Give epinephrine initially.
  • If patient does not respond to epinephrine and
    other usual therapy - Isoproterenol (a pure
    beta-agonist) 1 mg in 500 ml D5W starting at
    0.1 mcg/kg/min - Glucagon 1 mg IV over 2
    minutes

14
Fatal Food-induced Anaphylaxis
15
Use of epinephrine inFood Allergy
  • Epinephrine should be used immediately after
    accidental ingestion of foods that have caused
    anaphylactic reactions in the past.
  • An individual who is allergic to peanut, nuts,
    shellfish, and fish should immediately take
    epinephrine if they consume one of these foods.
  • A mild allergic reaction to other foods (e.g.
    minor hives,vomiting) may be treated with an
    antihistamine

16
Exercise-induced anaphylaxis
  • Exercise induces warmth, pruritus, urticaria.
  • Hypotension and upper airway obstruction may
    follow.
  • Some types associated with food allergies
    (e.g. celery, nuts, shellfish, wheat)
  • In other patients, anaphylaxis may occur after
    eating any meal (mechanism has not been
    identified)

17
Cold-induced anaphylaxis
  • Cold exposure leads to urticaria.
  • Drastic lowering of the whole body temperature
    (e.g. swimming in a cold lake) hypotensive
    event in addition to urticaria
  • mechanism unknown

18
DRUG ALLERGY
19
DRUG ALLERGY
  • Adverse drug reactions - majority of
    iatrogenic illnesses - 1 to 15 of drug
    courses
  • Non-immunologic (90-95) side effects, toxic
    reactions, drug interactions, secondary or
    indirect effects (eg. bacterial overgrowth)
    pseudoallergic drug rx (e.g. opiate reactions,
    ASA/NSAID reactions)
  • Immunologic (5-10)

20
Drugs as immunogens
  • Complete antigens - insulin, ACTH, PTH -
    enzymes chymopapain, streptokinase - foreign
    antisera e.g. tetanus antitoxin
  • Incomplete antigens - drugs with MW lt
    1000 - drugs acting as haptens bind to
    macromolecules (e.g. proteins, polysaccharides,
    cell membranes)

21
Factors that influence the development of drug
allergy
  • Route of administration - parenteral route
    more likely than oral route to cause
    sensitization and anaphylaxis - inhalational
    route respiratory or conjunctival
    manifestations only - topical high incidence
    of sensitization
  • Scheduling of administration -intermittent
    courses predispose to sensitization

22
Factors that influence the development of drug
allergy
  • Nature of the drug - 80 of allergic drug
    reactions due to - penicillin -
    cephalosporins - sulphonamides (sulpha
    drugs) - ASA/NSAIDs

23
Gell and Coombs reactions
  • Type 1 Immediate Hypersensitivity -
    IgE-mediated - occurs within minutes to
    4-6 hours of drug exposure
  • Type 2 Cytotoxic reactions - antibody-drug
    interaction on the cell surface results in
    destruction of the cell eg. hemolytic anemia
    due to penicillin, quinidine, quinine,cephalospori
    ns

24
Gell and Coombs reactions
  • Type 3 Serum sickness - fever, rash
    (urticaria, angioedema, palpable purpura),
    lymphadenopathy, splenomegaly, arthralgias -
    onset 2 days up to 4 weeks - penicillin
    commonest cause
  • Type 4 Delayed type hypersensitivity -
    sensitized to drug, the vehicle, or preservative
    (e.g. PABA, parabens, thimerosal)

25
Penicillin Allergy
  • beta lactam antibiotic
  • Type 1 reactions 2 of penicillin courses
  • Penicillin metabolites - 95
    benzylpenicilloyl moiety (the major
    determinant) - 5 benzyl penicillin G,
    penilloates, penicilloates (the minor
    determinants)

26
Penicillin Allergy
  • Skin tests Penicillin G, Prepen
    (benzyl-penicilloyl-polylysine) false negative
    rate of up to 7
  • Resolution of penicillin allergy - 50 lose
    penicillin allergy in 5 yr - 80-90 lose
    penicillin allergy in 10 yr

27
Cephalosporin allergy
  • beta-lactam ring and amide side chain similar to
    penicillin
  • degree of cross-reactivity in those with
    penicillin allergy 5 to 16
  • skin testing with penicillin determinants detects
    most but not all patients with cephalsporin
    allergy

28
Ampicillin rash
  • non-immunologic rash
  • maculopapular, non-pruritic rash
  • onsets 3 to 8 days into the antibiotic course
  • incidence 5 to 9 of ampicillin or amoxicillin
    courses 69 to 100 in those with infectious
    mononucleosis or acute lymphocytic leukemia
  • must be distinguished from hives secondary to
    ampicillin or amoxicillin

29
Sulphonamide hypersensitivity
  • sulpha drugs more antigenic than beta lactam
    antibiotics
  • common reactions drug eruptions (e.g.
    maculopapular or morbilliform rashes, erythema
    multiforme, etc.) Type 1 reactions
    urticaria, anaphylaxis, etc.
  • no reliable skin tests for sulpha drugs
  • re-exposure may cause exfoliative dermatitis,
    Stevens-Johnson syndrome

30
ASA and NSAID sensitivity
  • Pseudoallergic reactions -
    urticaria/angioedema - asthma -
    anaphylactoid reaction
  • prevalence 0.2 general population 8-19
    asthmatics 30-40 polyps sinusitis
  • ASA quatrad Asthma, Sinuitis, ASA sensitivity,
    nasal Polyps (ASAP syndrome)

31
ASA NSAID sensitivity
  • ASA sensitivity cross-reactive with all NSAIDs
    that inhibit cyclo-oxygenase

32
ASA NSAID sensitivity
  • no skin test or in vitro test to detect ASA or
    NSAID sensitivity
  • to prove or disprove ASA sensitivity oral
    challenge to ASA (in hospital setting)
  • ASA desensitization highly successful with
    ASA-induced asthma less successful with
    ASA-induced urticaria

33
Allergy skin testing
  • Skin tests to detect IgE-mediated drug reactions
    is limited to Complete antigens -
    insulin, ACTH, PTH - chymopapain,
    streptokinase - foreign antisera
    Incomplete antigens (drugs acting as
    haptens) - penicillins - local
    anesthetics - general anesthetics

34
Management of drug allergy
  • Identify most likely drugs (based on history).
  • Perform allergy skin tests (if available).
  • Avoidance of identified drug or suspected drug(s)
    is essential.
  • Avoid potential cross-reacting drugs (e.g. avoid
    cephalosporins in penicillin-allergic
    individuals).

35
Management of drug allergy
  • A Medic-Alert bracelet is recommended.
  • Use alternative medications, if at all possible.
  • Desensitize to implicated drug, if this drug is
    deemed essential.

36
Desensitization to medications
  • Basic approach administer gradually increasing
    doses of the drug over a period of hours to days,
    typically beginning with one ten-thousandth of a
    conventional dose
Write a Comment
User Comments (0)
About PowerShow.com